Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 12—December 2016

Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015

Johan van GriensvenComments to Author , Elhadj Ibrahima Bah, Nyankoye Haba, Alexandre Delamou, Bienvenu Salim Camara, Kadio Jean-Jacques Olivier, Hilde De Clerck, Helena Nordenstedt, Malcolm G. Semple, Michel Van Herp, Jozefien Buyze, Maaike De Crop, Steven Van Den Broucke, Lutgarde Lynen, Anja De Weggheleire, and the Ebola-Tx Consortium
Author affiliations: Institute of Tropical Medicine, Antwerp, Belgium (J. van Griensven, J. Buyze, M. De Crop, S. Van Den Broucke, L. Lynen, A. De Weggheleire); Donka National Hospital, Conakry, Guinea (E.I. Bah); National Blood Transfusion Center, Conakry (N. Haba, B.S. Camara, K.J.-J. Olivier); National Center for Training and Research in Rural Health of Maferinyah, Forecariah, Guinea (A. Delamou); Médecins Sans Frontières, Brussels, Belgium (H. De Clerck, H. Nordenstedt, M. Van Herp); University of Liverpool, Liverpool, United Kingdom (M.G. Semple)

Main Article

Table 1

Baseline characteristics of 85 Ebola patients recruited for the Ebola-Tx trial, Conakry, Guinea, 2015*

Characteristic Value
Age, median y (IQR) 30 (20–40)
10 (11.8)
M 37 (43.5)
48 (56.5)
Ct value on diagnostic Ebola PCR, n = 84

No. cycles, median (range) 26.8 (17.8–35.8)
<25 23 (27.4)
25.0–29.9 40 (47.6)
21 (25.0)
Duration of symptoms, median d (IQR), n = 74
4 (3–5)
Coexisting chronic medical condition 15 (17.6)
Infectious† 8 (9.4)
7 (8.2)
Selected symptoms on admission
Nausea and vomiting 43 (50.6)
Diarrhea 29 (34.1)

*Values are no. (%) patients except as indicated. Ct, cycle threshold; IQR, interquartile range.
†For example, tuberculosis, HIV, or malaria.
‡For example, diabetes mellitus, arterial hypertension, chronic cardiac, pulmonary disease, or renal disease.

Main Article

Page created: November 17, 2016
Page updated: November 17, 2016
Page reviewed: November 17, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.